Clinical Study of BCT301 Cell Injection Therapy for Refractory Autoimmune Diseases

Clinical trial NCT07301164 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07301164
Sponsor: Peking University Third Hospital
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

System Lupus Erythematosus Systemic Sclerosis (SSc)Inflammatory Myositis Antiphospholipid Syndrome ANCA Associated Vasculitis Sjogren Syndrome

Start date: 2025-12-11
Primary completion: 2027-12-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.